Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Blood|June 16, 2005
Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemiaRonald W Stam, Monique L den Boer, Pauline Schneider, et al.
Blood|May 20, 2006
Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocolsAmy Holleman, Monique L den Boer, Meyling H Cheok, et al.
Blood Advances|February 22, 2024
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutationsInge van Outersterp, Judith M Boer, Cesca van de Ven, et al.
British Journal of Haematology|April 5, 2014
Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemiaLieke C J van den Berk, Arian van der Veer, Marieke E Willemse, et al.
Haematologica|November 21, 2007
Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemiaAndrica C H de Vries, Ronald W Stam, Pauline Schneider, et al.
Nature Communications|August 7, 2012
Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathwayAzadeh Arabi, Karim Ullah, Rui M M Branca, et al.
Haematologica|January 26, 2006
In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemiaIsabelle Hubeek, Godefridus J Peters, Richard Broekhuizen, et al.
Hemasphere|July 16, 2024
Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experienceJudith M Boer, Uri Ilan, Aurélie Boeree, et al.
The New England Journal of Medicine|August 6, 2004
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatmentAmy Holleman, Meyling H Cheok, Monique L den Boer, et al.
Cancer Cell|March 7, 2003
Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classificationScott A Armstrong, Andrew L Kung, Meghann E Mabon, et al.
Pageof 12